Ascelis Peptides Private Limited - Company Profile

It is a paper private limited company based in Serilingampally, Telangana, India, established in 2025.
2025 Serilingampally, Telangana, India Active
Last Updated:
Access Report
About Ascelis Peptides Private Limited

Ascelis Peptides Private Limited, a active private limited company, was established on 04 March 2025 in Serilingampally, Telangana, India. Engaging in manufacturing within the paper sector, it holds CIN: U21001TS2025PTC195163. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹500.00 Cr and a paid-up capital of ₹330.00 Cr.

Its leadership includes Rajiv Pritidas Kakodkar (Additional Director), Chigurupati Krishna Prasad (Director), Umadevi Chigurupati (Director). It is based at 15Th Floor, Granules Tower, Botanical Garden Road, Serilingampally, Telangana, 500084.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001TS2025PTC195163

  • Registration Number

    195163

  • Incorporation Date

    04 March 2025

  • Authorized Capital

    ₹500.00 Cr

  • Paid-Up Capital

    ₹330.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 500.00 Cr
  • Paid Up Capital ₹ 330.00 Cr
  • Company Age 11 Months 13 Days
Company report

Ascelis Peptides Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ascelis Peptides Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ascelis Peptides Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajiv Pritidas Kakodkar Additional Director 26 Mar 2025 Current
Chigurupati Krishna Prasad Director 04 Mar 2025 Current
Umadevi Chigurupati Director 04 Mar 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ascelis Peptides.
Ascelis Peptides revenue growth over time
Ascelis Peptides profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ascelis Peptides?

Unlock access to Ascelis Peptides's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ascelis Peptides?

Unlock and access historical data on people associated with Ascelis Peptides, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ascelis Peptides, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascelis Peptides's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ascelis Peptides
Recent Activity within the Organization
  • Director Appointment

    The activity Mukesh Mahavirchand Surana was appointed as a Cfo was appointed as a Cfo on 03 Apr 2025 & has been associated with this company since 10 months 13 days . was completed.

  • Director Appointment

    The activity Anshuman Gupta was appointed as a Company Secretary was appointed as a Company Secretary on 03 Apr 2025 & has been associated with this company since 10 months 13 days . was completed.

  • Director Appointment

    Progress on Rajiv Pritidas Kakodkar was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2025 & has been associated with this company since 10 months 21 days . was documented.

  • Director Appointment

    Progress on Chigurupati Krishna Prasad was appointed as a Director was appointed as a Director on 04 Mar 2025 & has been associated with this company since 11 months 13 days . was documented.

  • Director Appointment

    The activity Umadevi Chigurupati was appointed as a Director was appointed as a Director on 04 Mar 2025 & has been associated with this company since 11 months 13 days . was completed.

  • Company Incorporation

    Ascelis Peptides Private Limited was registered on 04 Mar 2025 with Roc Hyderabad & aged 11 months 13 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ascelis Peptides Private Limited?

The CIN of Ascelis Peptides Private Limited is U21001TS2025PTC195163.

Where is Ascelis Peptides Private Limited headquartered?

Ascelis Peptides Private Limited is headquartered at 15Th Floor, Granules Tower, Botanical Garden Road, Serilingampally, Telangana, 500084.

When was Ascelis Peptides Private Limited incorporated?

Ascelis Peptides Private Limited was incorporated on 04 March 2025.

Who are the current directors of Ascelis Peptides Private Limited?

The current directors of Ascelis Peptides Private Limited are

What is the primary industry of Ascelis Peptides Private Limited?

The primary industry of Ascelis Peptides Private Limited is Paper.

Is Ascelis Peptides Private Limited a listed company?

Ascelis Peptides Private Limited is unlisted.

What is the capital structure of Ascelis Peptides Private Limited?

The authorized capital of Ascelis Peptides Private Limited is ₹500.00 Cr, and the paid-up capital is ₹330.00 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available